Epirubicin Hydrochloride - CAS 56390-09-1


Posted November 24, 2019 by BOC_Science

Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By BOC Sciences
Country United States
Categories Biotech
Last Updated November 24, 2019